Pleural Effusion

1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Rein Therapeutics
1 program
1
LTI-01Phase 21 trial
Active Trials
NCT04159831CompletedEst. Jul 2022
Rocket Pharmaceuticals
1 program
Vacuum-Based IPCN/A1 trial
Active Trials
NCT03831386Recruiting200Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rein TherapeuticsLTI-01
Rocket PharmaceuticalsVacuum-Based IPC

Clinical Trials (2)

Total enrollment: 200 patients across 2 trials

A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions

Start: Sep 2020Est. completion: Jul 2022
Phase 2Completed

Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System

Start: Jan 2019Est. completion: Dec 2026200 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 200 patients
2 companies competing in this space